Skip to main content
Yvonne Mowery, MD, Radiation Oncology, Pittsburgh, PA

YvonneMarieMoweryMD

Radiation Oncology Pittsburgh, PA

Central Nervous System Cancer, Head & Neck, Melanoma, Skin Cancer

Associate Professor, Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh

Dr. Mowery is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mowery's full profile

Already have an account?

  • Office

    5230 Centre Ave
    Pittsburgh, PA 15232
    Phone+1 412-623-7088
    Fax+1 412-623-6725

Summary

  • Yvonne M. Mowery, MD, PhD, DABR is a physician scientist and an Associate Professor of Radiation Oncology at University of Pittsburgh/UPMC Hillman Cancer Center. She is a board-certified radiation oncologist, specializing in treating head and neck cancer, base of skull tumors, and skin cancer. She received her MD and PhD in Pathology at Duke University in 2012, followed by completing an Internal Medicine internship and Radiation Oncology residency at Duke University in 2017. She was the Butler Harris Assistant Professor of Radiation Oncology at Duke University through May 2023 prior to moving to UPMC Hillman Cancer Center. Her laboratory focuses on studying head and neck cancer pathogenesis and mechanisms of overcoming radiation and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC), with a particular interest in DNA damage response pathways. Yvonne previously served as the Associate Center Director for Radioimmunotherapy for the Duke Cancer Institute Center of Cancer Immunotherapy, and she was awarded a 2021 American Society for Clinical Investigation Young Physician-Scientist Award. She is the PI of an investigator-initiated phase I trial (NCT04576091) evaluating the ATR inhibitor BAY 1895344 with pembrolizumab and stereotactic body radiation therapy for recurrent HNSCC. Her research support includes a K08 Career Development Award from the National Institute of Dental and Craniofacial Research and a Damon Runyon Clinical Investigator Award.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Radiation Oncology, 2013 - 2017
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 2012 - 2013
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2012

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2012 - 2025
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • VA State Medical License
    VA State Medical License 2020 - 2024
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation
    Yvonne M. Mowery, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Duke in the News: Political Polarization, COVID Evolution, and a New Human Organ
    Duke in the News: Political Polarization, COVID Evolution, and a New Human OrganOctober 23rd, 2020
  • Duke Cancer Researcher Receives Outstanding Investigator Award
    Duke Cancer Researcher Receives Outstanding Investigator AwardMarch 17th, 2016
  • Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer
    Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck CancerMarch 5th, 2024